Deerfield Management as of June 30, 2016
Portfolio Holdings for Deerfield Management
Deerfield Management holds 106 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Horizon Pharma | 8.9 | $226M | 14M | 16.47 | |
NxStage Medical | 3.8 | $98M | 4.5M | 21.68 | |
Gw Pharmaceuticals Plc ads | 3.6 | $91M | 992k | 91.57 | |
Portola Pharmaceuticals | 3.4 | $87M | 3.7M | 23.60 | |
Avexis | 3.3 | $85M | 2.2M | 38.02 | |
Adeptus Health Inc-class A | 3.2 | $83M | 1.6M | 51.66 | |
XenoPort | 3.2 | $82M | 12M | 7.04 | |
Horizon Pharma Plc convertible security | 3.0 | $75M | 83M | 0.91 | |
Healthways Inc note 1.500% 7/0 | 2.8 | $72M | 77M | 0.94 | |
Vanda Pharmaceuticals (VNDA) | 2.6 | $67M | 6.0M | 11.19 | |
Mylan Nv | 2.3 | $58M | 1.3M | 43.24 | |
Dbv Technologies S A | 2.2 | $57M | 1.7M | 32.62 | |
Xencor (XNCR) | 2.2 | $56M | 2.9M | 18.99 | |
Walgreen Boots Alliance (WBA) | 2.0 | $51M | 612k | 83.27 | |
Aac Holdings | 1.9 | $49M | 2.1M | 22.82 | |
Aetna | 1.8 | $45M | 366k | 122.13 | |
Aerie Pharmaceuticals | 1.7 | $44M | 2.5M | 17.60 | |
Trn 4% 04/01/45 | 1.7 | $44M | 48M | 0.92 | |
Flamel Technologies | 1.7 | $44M | 4.1M | 10.74 | |
Editas Medicine (EDIT) | 1.6 | $42M | 1.7M | 24.40 | |
DaVita (DVA) | 1.6 | $41M | 525k | 77.32 | |
Heartware Intl Inc note 3.500%12/1 | 1.6 | $40M | 40M | 0.99 | |
Array Biopharma Inc note 3.000% 6/0 | 1.5 | $38M | 45M | 0.84 | |
Syros Pharmaceuticals | 1.5 | $38M | 2.1M | 18.15 | |
Endologix Inc note 2.250%12/1 | 1.5 | $38M | 41M | 0.92 | |
eHealth (EHTH) | 1.4 | $37M | 2.6M | 14.02 | |
Wright Med Group Inc note 2.000% 2/1 | 1.4 | $37M | 40M | 0.92 | |
Zeltiq Aesthetics | 1.4 | $35M | 1.3M | 27.33 | |
Universal American | 1.3 | $33M | 4.3M | 7.58 | |
Relypsa | 1.2 | $31M | 1.7M | 18.50 | |
Heartware Intl Inc note 1.750%12/1 | 1.2 | $30M | 30M | 0.99 | |
Array BioPharma | 1.2 | $30M | 8.4M | 3.56 | |
Healthways | 1.1 | $29M | 2.5M | 11.55 | |
Humana (HUM) | 1.1 | $29M | 160k | 179.88 | |
Glaukos (GKOS) | 1.1 | $29M | 984k | 29.16 | |
Global Blood Therapeutics In | 1.1 | $29M | 1.7M | 16.59 | |
Acorda Therapeutics | 1.0 | $26M | 1.0M | 25.50 | |
Galapagos Nv- (GLPG) | 1.0 | $25M | 458k | 55.47 | |
Axogen (AXGN) | 0.9 | $23M | 3.4M | 6.88 | |
CIGNA Corporation | 0.9 | $22M | 171k | 127.99 | |
Molina Healthcare (MOH) | 0.8 | $22M | 436k | 49.90 | |
Lannett Company | 0.8 | $21M | 896k | 23.79 | |
Rite Aid Corporation | 0.8 | $20M | 2.6M | 7.49 | |
Cotiviti Hldgs | 0.8 | $19M | 900k | 21.13 | |
Spark Therapeutics | 0.7 | $19M | 368k | 51.13 | |
Alnylam Pharmaceuticals (ALNY) | 0.7 | $19M | 336k | 55.49 | |
Five Prime Therapeutics | 0.7 | $19M | 448k | 41.35 | |
Zafgen | 0.7 | $18M | 3.1M | 5.99 | |
Nivalis Therapeutics | 0.7 | $17M | 3.7M | 4.60 | |
Fluidigm Corporation convertible cor | 0.7 | $17M | 28M | 0.60 | |
Akari Therapeutics | 0.6 | $16M | 1.2M | 13.49 | |
Bluebird Bio (BLUE) | 0.6 | $15M | 338k | 43.29 | |
Select Medical Holdings Corporation (SEM) | 0.6 | $14M | 1.3M | 10.87 | |
Invuity | 0.5 | $13M | 1.3M | 9.53 | |
Proteon Therapeutics | 0.5 | $13M | 1.6M | 8.03 | |
Spectranetics Corp mtnf 2.625% 6/0 | 0.4 | $11M | 13M | 0.88 | |
Cytomx Therapeutics (CTMX) | 0.4 | $9.6M | 943k | 10.21 | |
Regenxbio Inc equity us cm (RGNX) | 0.4 | $9.4M | 1.2M | 8.00 | |
Nanostring Technologies (NSTGQ) | 0.3 | $8.5M | 675k | 12.60 | |
Foamix Pharmaceuticals | 0.3 | $8.1M | 1.3M | 6.35 | |
BioScrip | 0.3 | $7.6M | 3.0M | 2.55 | |
Incyte Corporation (INCY) | 0.3 | $7.3M | 91k | 79.98 | |
Alimera Sciences | 0.3 | $7.2M | 5.9M | 1.23 | |
Amag Pharmaceuticals Inc note 2.500% 2/1 | 0.3 | $7.2M | 6.5M | 1.10 | |
Epizyme | 0.2 | $6.4M | 622k | 10.24 | |
Essa Pharma | 0.2 | $6.4M | 2.2M | 2.95 | |
CAS Medical Systems | 0.2 | $5.9M | 3.2M | 1.84 | |
Loxo Oncology | 0.2 | $5.8M | 251k | 23.18 | |
Endochoice Hldgs | 0.2 | $5.9M | 1.2M | 4.90 | |
Kempharm | 0.2 | $5.7M | 1.4M | 3.98 | |
Aralez Pharmaceuticals | 0.2 | $5.4M | 1.6M | 3.30 | |
Rigel Pharmaceuticals | 0.2 | $5.2M | 2.3M | 2.23 | |
Alcobra | 0.2 | $4.8M | 1.1M | 4.49 | |
Myokardia | 0.2 | $4.6M | 375k | 12.40 | |
pSivida | 0.2 | $4.2M | 1.5M | 2.83 | |
Steadymed | 0.2 | $4.4M | 1.3M | 3.27 | |
Neos Therapeutics | 0.2 | $4.3M | 458k | 9.28 | |
Oxford Immunotec Global | 0.2 | $4.2M | 465k | 9.00 | |
Scynexis | 0.1 | $3.8M | 1.8M | 2.17 | |
Pronai Therapeutics | 0.1 | $3.2M | 1.6M | 1.99 | |
Genocea Biosciences | 0.1 | $2.8M | 687k | 4.10 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $2.6M | 1.9M | 1.33 | |
Voyager Therapeutics (VYGR) | 0.1 | $2.6M | 235k | 10.99 | |
Clovis Oncology | 0.1 | $2.3M | 170k | 13.72 | |
Ardelyx (ARDX) | 0.1 | $2.4M | 275k | 8.73 | |
Catabasis Pharmaceuticals | 0.1 | $2.4M | 644k | 3.70 | |
Alphatec Holdings | 0.1 | $1.7M | 5.0M | 0.35 | |
Pacira Pharmaceuticals (PCRX) | 0.1 | $1.7M | 50k | 33.74 | |
Agile Therapeutics | 0.1 | $1.9M | 250k | 7.61 | |
Acura Pharmaceuticals (ACUR) | 0.1 | $1.9M | 1.0M | 1.85 | |
Innocoll Hldgs | 0.1 | $1.7M | 303k | 5.51 | |
Threshold Pharmaceuticals | 0.1 | $1.7M | 2.6M | 0.64 | |
Aldeyra Therapeutics (ALDX) | 0.1 | $1.5M | 268k | 5.69 | |
Trillium Therapeutics, Inc. Cmn | 0.1 | $1.5M | 172k | 8.98 | |
Paratek Pharmaceuticals | 0.1 | $1.4M | 100k | 13.91 | |
Ocera Therapeutics | 0.0 | $1.1M | 573k | 1.90 | |
Corsicanto Ltd conv bnd | 0.0 | $1.0M | 1.0M | 1.02 | |
Streamline Health Solutions | 0.0 | $796k | 663k | 1.20 | |
Egalet | 0.0 | $805k | 162k | 4.96 | |
Cynapsus Therapeutics | 0.0 | $818k | 49k | 16.75 | |
Pacific Biosciences of California (PACB) | 0.0 | $444k | 63k | 7.04 | |
Endo International | 0.0 | $468k | 30k | 15.60 | |
Caredx (CDNA) | 0.0 | $221k | 51k | 4.32 | |
Tracon Pharmaceuticals | 0.0 | $296k | 68k | 4.38 | |
Rennova Health | 0.0 | $111k | 176k | 0.63 | |
Rennova Health Inc. Warrants *w | 0.0 | $26k | 645k | 0.04 |